At Siemens Healthineers, we are aware of the urgency and complexity of the current situation, and we are working hard to provide the best possible support to healthcare providers at each stage of COVID-19 patient care: diagnosis, prognosis, therapy and follow-up.
Our aspiration to drive innovations forward so people live healthier and longer lives is more valid today than ever before. We are stepping up as a partner to support healthcare systems helping them to deliver high-value care to patients and families. Please do not hesitate to contact us in case of questions or suggestions.
Due to high demand, availability in certain regions may be affected, please contact your local Siemens Healthineers organization for details.
We support you to provide the best possible care for patients
In the following overview we want to highlight parts of the portfolio from Siemens Healthineers that can support healthcare providers at each stage of COVID-19 patient care: diagnosis, prognosis, therapy and follow-up.
Our medical imaging, laboratory diagnostics and point-of-care testing solutions can support physicians to make a prognosis about the severity of a COVID-19 case, help treat the patient, and assist in the follow-up to find out when the patient has recovered.
At the same time our digital health solutions, services and consulting can support healthcare providers in protecting healthcare workers and increasing healthcare delivery capacity. For example, our digital services enable medical personnel to operate systems regardless of their location and thus with a potentially lower risk of infection.
COVID-19 response ꟷ Clinical
Rapid antigen testing for the detection of SARS-CoV-2
As society continues to navigate through the COVID-19 pandemic, there is a critical public health need to get ahead of the spread of the SARS-CoV-2 virus with a fast and simple test for all. The CLINITEST Rapid COVID-19 Antigen Test15 is a point-of-care cassette test that does not require central laboratory analyzers and hence eliminates transport delays and associated costs. It delivers results in 15 minutes.
Real-time PCR helps identify RNA from SARS-CoV-2
The new FTD SARS-CoV-2 real time PCR Assay (RUO)1 from Siemens Healthineers is now available2 for molecular laboratories. A dual-target design for SARS-CoV-2 identification provides assay robustness and optimal sensitivity, specificity, and inclusivity. The FTD SARS-CoV-2 Assay uses the same assay setup protocol and thermal-cycling profile as all FTD respiratory pathogens kits from Siemens Healthineers.3
Comprehensive lab testing
Fast, accurate detection and monitoring for health issues that may arise as part of COVID-19 disease management are critical. Our comprehensive portfolio of systems and extensive menu in immunoassay, chemistry, hematology, hemostasis, molecular, and urinalysis, in conjunction with automation, informatics, and services, can help support the essential role of laboratory diagnostics. We are expanding infectious-disease testing capabilities to address the COVID-19 pandemic, developing a SARS-CoV-2 laboratory serology assay4 to detect presence of IgM and IgG antibodies in blood, helping indicate whether a person has developed immunity. An antibody test can reveal if a person had COVID-19 even if they were asymptomatic or never diagnosed with the disease.
Manage patients in triage locations
In order to help inform clinical decisions during the COVID-19 crisis, labs need systems that are easy to install and run with broad menus to test patients for other related or unrelated medical conditions that may exist. Our compact, integrated chemistry and immunoassay testing system5 provides a simple user interface to rapidly mobilize testing with quick turnaround times for certain critical tests. A disposable, sealed cuvette design may help reduce contact with potentially infectious sample mixtures and aerosols.
COVID-19 response ꟷ Operational
Supporting radiologists in COVID-19 evaluation by applying Artificial Intelligence to images
Remote scanning assistance to ensure care continuity
Remote operations may help reduce staff exposure to infectious patients and may allow employees, who are under quarantine, to continue working. syngo Virtual Cockpit enables remote scanning assistance to imaging personnel – regardless of their geographic location. Assistance can even be provided from home with a simple laptop.13 With syngo Virtual Cockpit, your best technologists can assist on up to three exams at once, distributing their skills and experience across sites in real time. syngo Virtual Cockpit Lite offers remote scanning assistance from any networked computer within your facility, and enables access to one scanner at a time using syngo Expert-i.
Online education on COVID-19
Sharing image studies to expand reading expertise and capacities
COVID-19 response ꟷ Additional Resources
ECG Management Consultants – trusted advice on COVID-19
As your organization serves your community, ECG Management Consultants – A Siemens Healthineers Company – can offer support. We are providing accurate and actionable intelligence on COVID-19 preparedness and response as quickly as possible. Every day, our experts in healthcare strategy, finance, operations, and technology are sharing strategic and tactical, real-world approaches on how to help mitigate the effects of this crisis.
Explore our best practices on COVID-19
Stories from our people at the frontlines
Our perspective on COVID-19
The Siemens Healthineers leadership team regularly shares their thoughts via Linkedin blog posts. Find here the latest posts around the topic of COVID-19.
COVID-19 – Ten hypotheses on what we can learn from the crisis
The COVID-19 pandemic is a tough teacher, reminding us how closely our society, economy and health are intertwined. Which consequences will we draw from this crisis in the long term? Bernd Montag has ten hypotheses on what we can expect.
2 Available in limited quantities in April 2020.
3 Visit fast-trackdiagnostics.com for a list of compatible instruments. Customers are responsible for validating the assay on instruments listed in the compatibility list.
4 In development; not available for sale. Future availability cannot be guaranteed.
5 Product availability may vary from country to country and is subject to varying regulatory requirements.
6 Fang et al., Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR, Radiology 2020
7 Shi S, Qin M, Shen B, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. Published online March 25, 2020. doi:10.1001/jamacardio.2020.0950
8 Guo T, Fan Y, Chen M, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. Published online March 27, 2020. doi:10.1001/jamacardio.2020.1017
9 Inciardi RM, Lupi L, Zaccone G, et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. Published online March 27, 2020. doi:10.1001/jamacardio.2020.1096
10 Not available in all countries
11 For Research Use Only. Not for use in diagnostic procedures.
12 AI-Rad Companion Chest X-ray is currently not for sales in the United States and other selected countries.
13 A secure VPN connection to the department network is required. Other appropriately trained personnel must be in the room to care for patient, position the patient, and manually start the scan.
14 The DICOM viewer is not intended for diagnostic display. Due to regulations data exchange between data center regions is restricted. The products/features/service offerings are not commercially available in all countries. If the services are not marketed in countries due to regulatory or other reasons, the service offering cannot be guaranteed. Please contact your local Siemens organization for further details.
15 Under review by the U.S. FDA for Emergency Use Authorization (EUA). Product availability may vary from country to country and is subject to varying regulatory requirements.
The products/features and/or service offerings (here mentioned) are not commercially available in all countries and/or for all modalities. If the services are not marketed in countries due to regulatory or other reasons, the service offering cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.
Due to high demand, availability in certain regions may be affected, please contact your local Siemens Healthineers representative for details.